This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Magnetic Resonance Imaging  • PET/ SPECT Imaging  • Alert me on articles by topic

The Future for Single-Modality Imaging in Oncology?

Lennart Blomqvist, MD, PhD; Michael R. Torkzad, MD

JAMA. 2003;290:3248-3249.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Planning treatment for patients with cancer relies heavily on imaging information to establish tumor stage at presentation and to assess tumor response to treatment. It is also becoming increasingly desirable to define precisely the tumor target to deliver various forms of local treatment as accurately as possible. Because different imaging modalities have different inherent soft tissue contrast properties, use of several imaging modalities in a stepwise approach is common.

Computed tomography (CT) is the most commonly used technology in the evaluation of patients with cancer. Advances in technology of spiral CT with multiple detectors has significantly improved its efficacy and allows for rapid image acquisition of large parts of the body with thin slices during a single breath hold and, if desired also for whole-body scanning. However, the soft tissue contrast properties of CT for tumor staging are limited in terms of . . . [Full Text of this Article]

Author Affiliation: Department of Diagnostic Radiology, Karolinska Hospital, Stockholm, Sweden.